title: Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
abstract: Amorphous solid dispersions (ASDs) are of great interest as enabling formulations because of their ability to increase the bioavailability of poorly soluble drugs. However, the dissolution of these formulations under nonsink dissolution conditions results in highly supersaturated drug solutions that can undergo different types of phase transitions. The purpose of this study was to characterize the phase behavior of solutions resulting from the dissolution of model ASDs as well as the degree of supersaturation attained. Danazol was chosen as a poorly water-soluble model drug, and three polymers were used to form the dispersions: polyvinylpyrrolidone (PVP), hydroxypropylmethyl cellulose (HPMC), and hydroxypropylmethyl cellulose acetate succinate (HPMCAS). Dissolution studies were carried out under nonsink conditions, and solution phase behavior was characterized using several orthogonal techniques. It was found that liquid-liquid phase separation (LLPS) occurred following dissolution and prior to crystallization for most of the dispersions. Using flux measurements, it was further observed that the maximum attainable supersaturation following dissolution was equivalent to the amorphous solubility. The dissolution of the ASDs led to sustained supersaturation, the duration of which varied depending on the drug loading and the type of polymer used in the formulation. The overall supersaturation profile observed thus depended on a complex interplay between dissolution rate, polymer type, drug loading, and the kinetics of crystallization.
authors.affiliation: Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University , West Lafayette, Indiana 47907, United States.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Jackson
authors.affiliation: Bristol-Myers Squibb Company , New Brunswick, New Jersey 08903, United States.
authors.forename: Umesh S
authors.initials: US
authors.lastname: Kestur
authors.affiliation: Bristol-Myers Squibb Company , New Brunswick, New Jersey 08903, United States.
authors.forename: Munir A
authors.initials: MA
authors.lastname: Hussain
authors.affiliation: Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University , West Lafayette, Indiana 47907, United States.
authors.forename: Lynne S
authors.initials: LS
authors.lastname: Taylor
mesh_terms: D003460:Crystallization; D003613:Danazol / Q000737:chemistry*; D065347:Hypromellose Derivatives / Q000737:chemistry; D008747:Methylcellulose / Q000031:analogs & derivatives / Q000737:chemistry; D011108:Polymers / Q000737:chemistry*; D011205:Povidone / Q000737:chemistry
chemical_list: D011108:Polymers; D065347:Hypromellose Derivatives; C048331:hydroxypropylmethylcellulose acetate succinate; D008747:Methylcellulose; D011205:Povidone; D003613:Danazol
keywords: amorphous solid dispersion; amorphous solubility; crystallization; dissolution; polymers; supersaturation